Nociceptin (1-11), (Orphanin FQ, or OFQ/N) (1-11) is an N-terminal fragment of nociceptin used to probe partial activation of the NOP receptor. Its sequence preserves critical aromatic and basic residues involved in binding. Researchers employ it to dissect contribution of the N-terminus to signaling efficacy. The peptide aids structure–activity analysis of nociceptin analogs.
CAT No: N08001
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.